Role of SUMO-Specific Protease 2 in Reprogramming Cellular Glucose Metabolism

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Tang, Shuang ^a,b   Huang, Gang ^a,b   Tong, Xuemei ^a   Xu, Lian ^a,b   Cai, Rong ^a   Li, Jie ^a   Zhou, Xiang ^a,b   Song, Shaoli ^a,b   Huang, Chen ^a,b   Cheng, Jinke ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ADENOSINE TRIPHOSPHATE; GLUCOSE; LACTIC ACID; PROTEIN KINASE B; PROTEINASE; SUMO SPECIFIC PROTEASE 2; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER TISSUE; CELL STRAIN MCF 7; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; GLUCOSE METABOLISM; GLUCOSE OXIDATION; GLUCOSE TRANSPORT; GLYCOLYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; MITOCHONDRIAL RESPIRATION; PHENOTYPE; PROTEIN EXPRESSION; REGULATORY MECHANISM;

ADENOSINE TRIPHOSPHATE; ANIMALS; BIOLOGICAL TRANSPORT; CITRIC ACID CYCLE; CYSTEINE ENDOPEPTIDASES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE KNOCKOUT TECHNIQUES; GLUCOSE; GLYCOLYSIS; HUMANS; LACTIC ACID; MCF-7 CELLS; MICE; OXIDATION-REDUCTION; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RNA, MESSENGER;

EID: 84877728052     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0063965     Document Type: Article

References (24)

1. Hay RT, (2005) SUMO: a history of modification. Mol Cell 18: 1-12.
2. Yeh ET, Gong L, Kamitani T, (2000) Ubiquitin-like proteins: new wines in new bottles. Gene 248: 1-14.
3. Cheng J, Kang X, Zhang S, Yeh ET, (2007) SUMO-specific protease 1 is essential for stabilization of HIF1alpha during hypoxia. Cell 131: 584-595.
4. Kroemer G, Pouyssegur J, (2008) Tumor cell metabolism: cancer's Achilles' heel. Cancer Cell 13: 472-482.
5. Jiang M, Chiu SY, Hsu W, (2011) SUMO-specific protease 2 in Mdm2-mediated regulation of p53. Cell Death Differ 18: 1005-1015.
6. Kang X, Qi Y, Zuo Y, Wang Q, Zou Y, et al. (2010) SUMO-specific protease 2 is essential for suppression of polycomb group protein-mediated gene silencing during embryonic development. Mol Cell 38: 191-201.
7. Xu Y, Li J, Zuo Y, Deng J, Wang LS, et al. (2011) SUMO-specific protease 1 regulates the in vitro and in vivo growth of colon cancer cells with the upregulated expression of CDK inhibitors. Cancer Lett 309: 78-84.
8. Thanan R, Murata M, Ma N, Hammam O, Wishahi M, et al. (2012) Nuclear localization of COX-2 in relation to the expression of stemness markers in urinary bladder cancer. Mediators Inflamm 2012: 165879.
9. Tuttle SW, Maity A, Oprysko PR, Kachur AV, Ayene IS, et al. (2007) Detection of reactive oxygen species via endogenous oxidative pentose phosphate cycle activity in response to oxygen concentration: implications for the mechanism of HIF-1alpha stabilization under moderate hypoxia. J Biol Chem 282: 36790-36796.
10. Zhao F, Mancuso A, Bui TV, Tong X, Gruber JJ, et al. (2010) Imatinib resistance associated with BCR-ABL upregulation is dependent on HIF-1alpha-induced metabolic reprograming. Oncogene 29: 2962-2972.
11. Gerhart-Hines Z, Rodgers JT, Bare O, Lerin C, Kim SH, et al. (2007) Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1alpha. EMBO J 26: 1913-1923.
12. Wende AR, Huss JM, Schaeffer PJ, Giguere V, Kelly DP, (2005) PGC-1alpha coactivates PDK4 gene expression via the orphan nuclear receptor ERRalpha: a mechanism for transcriptional control of muscle glucose metabolism. Mol Cell Biol 25: 10684-10694.
13. Dai XQ, Plummer G, Casimir M, Kang Y, Hajmrle C, et al. (2011) SUMOylation regulates insulin exocytosis downstream of secretory granule docking in rodents and humans. Diabetes 60: 838-847.
14. Pandey D, Chen F, Patel A, Wang CY, Dimitropoulou C, et al. (2011) SUMO1 negatively regulates reactive oxygen species production from NADPH oxidases. Arterioscler Thromb Vasc Biol 31: 1634-1642.
15. Agbor TA, Cheong A, Comerford KM, Scholz CC, Bruning U, et al. (2011) Small ubiquitin-related modifier (SUMO)-1 promotes glycolysis in hypoxia. J Biol Chem 286: 4718-4726.
16. Young CD, Anderson SM, (2008) Sugar and fat - that's where it's at: metabolic changes in tumors. Breast Cancer Res 10: 202.
17. Nguyen QD, Perumal M, Waldman TA, Aboagye EO, (2011) Glucose metabolism measured by [(1)F]fluorodeoxyglucose positron emission tomography is independent of PTEN/AKT status in human colon carcinoma cells. Transl Oncol 4: 241-248.
18. Macheda ML, Rogers S, Best JD, (2005) Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer. J Cell Physiol 202: 654-662.
19. Elstrom RL, Bauer DE, Buzzai M, Karnauskas R, Harris MH, et al. (2004) Akt stimulates aerobic glycolysis in cancer cells. Cancer Res 64: 3892-3899.
20. Wolf A, Agnihotri S, Micallef J, Mukherjee J, Sabha N, et al. (2011) Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme. J Exp Med 208: 313-326.
21. Hernandez-Aya LF, Gonzalez-Angulo AM, (2011) Targeting the phosphatidylinositol 3-kinase signaling pathway in breast cancer. Oncologist 16: 404-414.
22. Huang J, Yan J, Zhang J, Zhu S, Wang Y, et al. (2012) SUMO1 modification of PTEN regulates tumorigenesis by controlling its association with the plasma membrane. Nat Commun 3: 911.
23. Gonzalez-Santamaria J, Campagna M, Ortega-Molina A, Marcos-Villar L, de la Cruz-Herrera CF, et al. (2012) Regulation of the tumor suppressor PTEN by SUMO. Cell Death Dis 3: e393.
24. Cheng J, Bawa T, Lee P, Gong L, Yeh ET, (2006) Role of desumoylation in the development of prostate cancer. Neoplasia 8: 667-676.